Gong, W.; Huang, D.; Zhou, T.; Zhu, X.; Huang, Y.; Lv, Y.; Zhang, Y.; Liu, Z.; Zeng, F.; Wu, S.
Decoding Resistin Gene Polymorphisms: Implications for Lung Cancer Risk and Clinical Outcomes of Platinum-Based Chemotherapy. Biomedicines 2025, 13, 291.
https://doi.org/10.3390/biomedicines13020291
AMA Style
Gong W, Huang D, Zhou T, Zhu X, Huang Y, Lv Y, Zhang Y, Liu Z, Zeng F, Wu S.
Decoding Resistin Gene Polymorphisms: Implications for Lung Cancer Risk and Clinical Outcomes of Platinum-Based Chemotherapy. Biomedicines. 2025; 13(2):291.
https://doi.org/10.3390/biomedicines13020291
Chicago/Turabian Style
Gong, Weijing, Dandan Huang, Tao Zhou, Xinxin Zhu, Yifei Huang, Yongning Lv, Yu Zhang, Zhaoqian Liu, Fang Zeng, and Sanlan Wu.
2025. "Decoding Resistin Gene Polymorphisms: Implications for Lung Cancer Risk and Clinical Outcomes of Platinum-Based Chemotherapy" Biomedicines 13, no. 2: 291.
https://doi.org/10.3390/biomedicines13020291
APA Style
Gong, W., Huang, D., Zhou, T., Zhu, X., Huang, Y., Lv, Y., Zhang, Y., Liu, Z., Zeng, F., & Wu, S.
(2025). Decoding Resistin Gene Polymorphisms: Implications for Lung Cancer Risk and Clinical Outcomes of Platinum-Based Chemotherapy. Biomedicines, 13(2), 291.
https://doi.org/10.3390/biomedicines13020291